Biogen testing channel support

NASDAQ:BIIB   Biogen Inc.
Biogen Inc. (BIIB) currently testing channel support, able to absorb weekly selling pressures.

From here, (BIIB) can recover and turn higher to channel resistance, eliciting gains of 20-25% over the following 2 - 3 months.

A settlement above this week’s high would accelerate this upward momentum.

Inversely, closing below this channel support would indicate losses of 20% over the following 2 - 3 months where (BIIB) can bottom out into Q4.

Anthony Speciale, founder of Speciale Analysis offers a LIVE Price Action trading program designed to serve retail traders of all experience levels.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.